CERN Foundation
Image of researchers being featured in this week's webinar.

AYA and CNS Tumors: Unmet Needs and Opportunities for Collaboration
Wednesday, October 30, 2024, 11 a.m. to 3 p.m. ET

The NCI Cancer Moonshot℠ and Center for Cancer Research Cancer Moonshot programs, NCI-CONNECT and MyPART, are co-hosting a webinar titled, “AYA and Primary CNS Tumors: Unmet Needs and Opportunities for Collaboration.”

The webinar is an engagement and educational event open to the public, including health care providers, patients, caregivers, and advocates. The goal of the webinar is to continue to bring awareness to the unmet needs, gaps in care, and opportunities for collaboration in care and development of effective therapies for adolescents and young adults (AYA) with primary central nervous system (CNS) tumors.

REGISTER NOW
 
 

CERN COMMUNITY

Liz and Julio Piņa Share
Their Experience with
Clinical Trials

Image of Liza dn Julio telling their brain tumor story.

Clinical trials provide early access to potentially beneficial treatments, advance science, and play an integral role in developing new and improved treatments for brain tumors. The National Comprehensive Cancer Network (NCCN) believes the best management of any patient with cancer is a clinical trial, but the idea of enrolling in a clinical trial may seem daunting. In this video, hear why Julio Piņa, a patient with anaplastic ependymoma, and his wife Liz enrolled in a trial and what the process looked like.

Learn more about clinical trials through NBTS’s MyTumorID campaign, and sign up to receive the latest news about clinical trials, biomarker testing, and more.
LEARN MORE
 
 
A little boy holds a butterfly, a symbol of hope for brain tumor survivors.

Support the Ependymoma Fund for Research and Education

With your generous support, we will continue to expand our efforts to improve the care and outcome of people with ependymoma.
MAKE A GIFT
 
CERN Foundation Logo.

The CERN Foundation and the National Brain Tumor Society have joined forces to help people with ependymoma and advance ependymoma research toward the development of new and better treatments through the creation of the Ependymoma Fund for Research and Education. Today, the CERN Foundation is officially a designated program of the National Brain Tumor Society. Donations to the Ependymoma Fund for Research and Education will be made on the NBTS website and used to support research efforts that will benefit both ependymoma patients and research through CERN. Emphasis will be placed on CERN’s historical model of supporting work that translates basic science into clinical practice. The Fund will also address overcoming barriers to clinical trial accrual and the development of new clinical studies for ependymoma patients. Additional funds will be used to support educational efforts through print, media, and awareness events. The new collaborative Ependymoma Fund will continue CERN’s practice and tradition of involving and collaborating with other scientists, medical providers, foundations and supporters of ependymoma research.
LEARN MORE
 
 

CONNECT WITH US!  
Visit NBTS on Facebook. Visit NBTS on Twitter. Visit NBTS on YouTube.
 

National Brain Tumor Society unrelentingly invests in, mobilizes, and unites our community to discover a cure, deliver effective treatments, and advocate for patients and care partners. Our vision is to conquer and cure brain tumors—once and for all.

Privacy Policy • Update Email Preference or Unsubscribe

Update email preferences or unsubscribe

© National Brain Tumor Society - All Rights Reserved.
55 Chapel Street, Suite 006, Newton, MA 02458
617.924.9997 • Contact Us